Micropulse Transscleral Cyclophotocoagulation; Efficacy Endpoints For The Treatment Of Refractory Pediatric Glaucoma: A Retrospective Cohort Study

 To study the success, failure and Safety among the group of interest in short- and long-term periods after conducting micropulse cyclophotocoagulation (MP-CPC) therapy.

A retrospective cohort study of pediatric patients (0-16 years of age at the time of surgery) with refractory glaucoma underwent MP-CPC by expert surgeons at King Khalid Eye Hospital. Definition of Absolute success: IOP between 6 and 21 mmHg (when for short term and when for long term outcome). Qualified success: IOP between 6 and 21 mmHg or ≥20% of the baseline IOP with the help of medications. Failure definition: Inability to meet complete success, qualified success, or having sight-threatening complications in the postoperative period.

A total of 44 eyes of 40 patients were included in the current study.The majority of recruited eyes were left eyes 28 (63.6%) where most of their lens’s status was phakic 27 (61.4%) where the intervention was targeting 4 quadrants, 21 (47.7%). commonest diagnosed was congenital glaucoma, 24 (54.5%). The history of previous glaucoma surgery was detected in 35 (79.5%) of the eyes with Tube shunt intervention solely in 10 (22.7%) of them, and Tube shunt with other intervention in other 12 (27.3%) of the eyes.